Literature DB >> 21950494

Variant screening of the RHD gene in a large cohort of subjects with D phenotype ambiguity: report of 17 novel rare alleles.

Yann Fichou1, Cédric Le Maréchal, Laurence Bryckaert, Christine Guerry, Caroline Bénech, Isabelle Dupont, Déborah Jamet, Claude Férec, Jian-Min Chen.   

Abstract

BACKGROUND: A considerable number of RHD alleles responsible for weak and partial D phenotypes have been identified over the past decade. Two particular concerns, namely, 1) that red blood cells of these phenotypes may cause anti-D immunization when transfused to D- recipients and 2) that serologic determination of these phenotypes is often doubtful, make genetic analysis of the RHD gene highly desirable. STUDY DESIGN AND METHODS: Blood samples that displayed D phenotype ambiguity (as determined by serologic analyses) were collected from several sites of the Etablissement Français du Sang and subjected to RHD variant screening by means of a previously established denaturing high-performance liquid chromatography method followed by direct sequencing.
RESULTS: Systematic screening of the RHD coding sequences as well as the exon-intron boundaries identified DNA variants in 755 of the 806 samples analyzed. In particular, this resulted in the identification of 10 novel single-nucleotide substitutions and seven novel complex alleles.
CONCLUSION: This study further increased the already large repertoire of RHD allelic variants. Whereas most of the newly found variants are putative weak or partial D alleles, most of the complex alleles are readily understandable in the present phylogenetic model of RHD.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21950494     DOI: 10.1111/j.1537-2995.2011.03350.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania.

Authors:  Merita Xhetani; Irena Seferi; Claude Férec; Grigor Zoraqi; Yann Fichou
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

2.  The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens.

Authors:  Kshitij Srivastava; Helene Polin; Sherry Lynne Sheldon; Franz Friedrich Wagner; Christoph Grabmer; Christian Gabriel; Gregory Andrew Denomme; Willy Albert Flegel
Journal:  Transfusion       Date:  2016-08-02       Impact factor: 3.157

3.  The synonymous nucleotide substitution RHD 1056C>G alters mRNA splicing associated with serologically weak D phenotype.

Authors:  Sejong Chun; Jae Won Yun; Geon Park; Duck Cho
Journal:  J Clin Lab Anal       Date:  2017-09-19       Impact factor: 2.352

4.  D category IV: a group of clinically relevant and phylogenetically diverse partial D.

Authors:  Inge von Zabern; Franz F Wagner; Joann M Moulds; John J Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

5.  RHD variants in Polish blood donors routinely typed as D-.

Authors:  Agnieszka Orzińska; Katarzyna Guz; Helene Polin; Monika Pelc-Kłopotowska; Justyna Bednarz; Agata Gieleżyńska; Beata Sliwa; Małgorzata Kowalewska; Elżbieta Pawłowska; Bogusława Włodarczyk; Małgorzata Malaga Alicja Żmudzin; Magdalena Krzemienowska; Kshitij Srivastava; Bogumiła Michalewska; Christian Gabriel; Willy A Flegel; Ewa Brojer
Journal:  Transfusion       Date:  2013-05-01       Impact factor: 3.157

6.  Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China.

Authors:  Xu Zhang; Guiji Li; Zhuren Zhou; Chaopeng Shao; Xuying Huang; Lichun Li; Xiaofeng Li; Ying Liu; Hua Fan; Jianping Li
Journal:  J Transl Med       Date:  2019-11-27       Impact factor: 5.531

7.  The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals.

Authors:  Yanling Ying; Jingjing Zhang; Xiaozhen Hong; Xianguo Xu; Ji He; Faming Zhu
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.